Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

Completed

• Conditions: Bipolar Disorder

• Registration Number: NCT00660712
• Lead Sponsor: AstraZeneca

Brief Summary

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-03
• Study First Submitted: 2008-04-15
• Study First Submitted QC: 2008-04-15
• Study First Posted: 2008-04-17
• Study Completion: 2009-03
• Status Verified: 2009-05
• Last Update Submitted: 2009-05-22
• Last Update Posted: 2009-05-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1018

Inclusion Criteria

• Patients previously or currently diagnosed with bipolar disorder
• Patients (or any of their relatives) who give a written informed consent.

Read More

Exclusion Criteria

• Patients who were previously included in this study.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary Outcome Measures

Name	Time	Method
Evaluation of co-morbid psychiatric diseases
Identification of treatment modalities selected according to the disease phase
Identification of the number of first degree relatives diagnosed with bipolar disorder
Evaluation of the relationship between patient and disease characteristics
Evaluation of the time period that elapsed since the diagnosis of bipolar disorder

Trial Locations

Locations (1)

Research Site; 🇹🇷 Trabzon, Turkey